Cargando…
Molecular profiling of non-small cell lung cancer
Lung cancer is generally treated with conventional therapies, including chemotherapy and radiation. These methods, however, are not specific to cancer cells and instead attack every cell present, including normal cells. Personalized therapies provide more efficient treatment options as they target t...
Autores principales: | Forsythe, Marika L., Alwithenani, Akram, Bethune, Drew, Castonguay, Mathieu, Drucker, Arik, Flowerdew, Gordon, French, Daniel, Fris, John, Greer, Wenda, Henteleff, Harry, MacNeil, Mary, Marignani, Paola, Morzycki, Wojciech, Plourde, Madelaine, Snow, Stephanie, Xu, Zhaolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406040/ https://www.ncbi.nlm.nih.gov/pubmed/32756609 http://dx.doi.org/10.1371/journal.pone.0236580 |
Ejemplares similares
-
Profiling non-small cell lung cancer reveals that PD-L1 is associated with wild type EGFR and vascular invasion, and immunohistochemistry quantification of PD-L1 correlates weakly with RT-qPCR
por: Alwithenani, Akram, et al.
Publicado: (2021) -
Cross sectional analysis of student-led surgical societies in fostering medical student interest in Canada
por: Song, Jin Soo A., et al.
Publicado: (2019) -
Single-cell RNA sequencing for the identification of early-stage lung cancer biomarkers from circulating blood
por: Kim, Jinhong, et al.
Publicado: (2021) -
Systematic Analysis of Spleen Tyrosine Kinase Expression and its Clinical Outcomes in Various Cancers
por: Alwithenani, Akram I., et al.
Publicado: (2020) -
Loss of lkb1 Expression Reduces the Latency of ErbB2-Mediated Mammary Gland Tumorigenesis, Promoting Changes in Metabolic Pathways
por: Andrade-Vieira, Rafaela, et al.
Publicado: (2013)